Monografie
Optimization of engineered T cells for the use in melanoma immunotherapy
- Sprache
-
Englisch
- Identifier
-
1204257809
- Thema
-
Melanoma; T cells; Immunotherapy
- Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Simon, Bianca
- Nimmerjahn, Falk
- Nimmerjahn, Falk
Ähnliche Objekte (12)
Optimization of adoptive immunotherapy with genetically engineered T cells
Immunotherapy of malignant melanoma
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
The influence of hypoxia on RIG-I-mediated melanoma immunotherapy
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Optimization of adoptive immunotherapy with genetically engineered T cells
Immunotherapy of malignant melanoma
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
The influence of hypoxia on RIG-I-mediated melanoma immunotherapy
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Optimization of adoptive immunotherapy with genetically engineered T cells
Immunotherapy of malignant melanoma
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
The influence of hypoxia on RIG-I-mediated melanoma immunotherapy
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model